Skip to main content
Top
Published in: Journal of Ocular Biology, Diseases, and Informatics 1/2010

Open Access 01-03-2010

Ocular disease in patients with ANCA-positive vasculitis

Authors: Angela S. Watkins, John H. Kempen, Dongseok Choi, Teresa L. Liesegang, S. S. Pujari, Craig Newcomb, Robert B. Nussenblatt, James T. Rosenbaum, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, Eric B. Suhler, Justine R. Smith

Published in: Journal of Ocular Biology, Diseases, and Informatics | Issue 1/2010

Login to get access

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis—the term recently applied to Wegener's granulomatosis—is a rare multi-system inflammation characterized by necrotizing granulomas and vasculitis. We investigated the ocular manifestations of this disease in a group of patients drawn from five inflammatory eye disease clinics across the United States. Of 8,562 persons with ocular inflammation, 59 individuals were diagnosed with ANCA-positive vasculitis; 35 males and 21 females, aged 16 to 96 years, were included in this study. Ocular diagnoses were scleritis (75.0%), uveitis (17.9%), and other ocular inflammatory conditions (33.9%) including peripheral ulcerative keratitis and orbital pseudotumor. Mean duration of ocular disease was 4.6 years. Oral corticosteroids and other systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease.
Literature
3.
go back to reference Sarraf P, Sneller MC. Pathogenesis of Wegener's granulomatosis: current concepts. Expert Rev Mol Med. 2005;7(8):1–19.CrossRefPubMed Sarraf P, Sneller MC. Pathogenesis of Wegener's granulomatosis: current concepts. Expert Rev Mol Med. 2005;7(8):1–19.CrossRefPubMed
4.
go back to reference Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996;39(1):87–92.CrossRefPubMed Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996;39(1):87–92.CrossRefPubMed
5.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98.PubMed Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98.PubMed
6.
go back to reference Pakrou N, Selva D, Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35(5):284–92.CrossRefPubMed Pakrou N, Selva D, Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35(5):284–92.CrossRefPubMed
7.
go back to reference Robin JB, Schanzlin DJ, Meisler DM, et al. Ocular involvement in the respiratory vasculitides. Surv Ophthalmol. 1985;30(2):127–40.CrossRefPubMed Robin JB, Schanzlin DJ, Meisler DM, et al. Ocular involvement in the respiratory vasculitides. Surv Ophthalmol. 1985;30(2):127–40.CrossRefPubMed
8.
go back to reference Fechner FP, Faquin WC, Pilch BZ. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope. 2002;112(11):1945–50.CrossRefPubMed Fechner FP, Faquin WC, Pilch BZ. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope. 2002;112(11):1945–50.CrossRefPubMed
9.
go back to reference Bhatia A, Yadava U, Goyal JL, Chaturvedi KU. Limited Wegener's granulomatosis of the orbit: a case study and review of literature. Eye. 2005;19(1):102–4.CrossRefPubMed Bhatia A, Yadava U, Goyal JL, Chaturvedi KU. Limited Wegener's granulomatosis of the orbit: a case study and review of literature. Eye. 2005;19(1):102–4.CrossRefPubMed
10.
go back to reference Bambery P, Sakhuja V, Gupta A, et al. Wegener's granulomatosis in north India. An analysis of eleven patients. Rheumatol Int. 1987;7(6):243–7.CrossRefPubMed Bambery P, Sakhuja V, Gupta A, et al. Wegener's granulomatosis in north India. An analysis of eleven patients. Rheumatol Int. 1987;7(6):243–7.CrossRefPubMed
11.
go back to reference Sadiq SA, Jennings CR, Jones NS, Downes RN. Wegener's granulomatosis: the ocular manifestations revisited. Orbit. 2000;19(4):253–61.CrossRefPubMed Sadiq SA, Jennings CR, Jones NS, Downes RN. Wegener's granulomatosis: the ocular manifestations revisited. Orbit. 2000;19(4):253–61.CrossRefPubMed
12.
go back to reference Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63(1):131–41.CrossRefPubMed Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63(1):131–41.CrossRefPubMed
13.
go back to reference Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983;90(3):279–90.PubMed Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983;90(3):279–90.PubMed
14.
go back to reference Charles SJ, Meyer PA, Watson PG. Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol. 1991;75(4):201–7.CrossRefPubMed Charles SJ, Meyer PA, Watson PG. Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol. 1991;75(4):201–7.CrossRefPubMed
15.
go back to reference Straatsma BR. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol. 1957;44(6):789–99.PubMed Straatsma BR. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol. 1957;44(6):789–99.PubMed
16.
go back to reference Cutler WM, Blatt IM. The ocular manifestations of lethal midline granuloma (Wegener's granulomatosis). Am J Ophthalmol. 1956;42(1):21–35.PubMed Cutler WM, Blatt IM. The ocular manifestations of lethal midline granuloma (Wegener's granulomatosis). Am J Ophthalmol. 1956;42(1):21–35.PubMed
17.
go back to reference Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. 2008;15(1):47–55.CrossRefPubMed Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. 2008;15(1):47–55.CrossRefPubMed
18.
go back to reference Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009;339:b2480.CrossRefPubMed Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009;339:b2480.CrossRefPubMed
19.
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
21.
go back to reference Harper SL, Letko E, Samson CM, et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001;28(5):1025–32.PubMed Harper SL, Letko E, Samson CM, et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001;28(5):1025–32.PubMed
22.
go back to reference White ES, Lynch JP. Pharmacological therapy for Wegener's granulomatosis. Drugs. 2006;66(9):1209–28.CrossRefPubMed White ES, Lynch JP. Pharmacological therapy for Wegener's granulomatosis. Drugs. 2006;66(9):1209–28.CrossRefPubMed
23.
go back to reference Metzler C, Miehle N, Manger K, et al. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford). 2007;46(7):1087–91.CrossRef Metzler C, Miehle N, Manger K, et al. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford). 2007;46(7):1087–91.CrossRef
24.
go back to reference Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352(4):351–61.CrossRef Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352(4):351–61.CrossRef
25.
go back to reference Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104(4):683–94.PubMed Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104(4):683–94.PubMed
26.
go back to reference Woo TL, Francis IC, Wilcsek GA, et al. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology. 2001;108(9):1535–43.CrossRefPubMed Woo TL, Francis IC, Wilcsek GA, et al. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology. 2001;108(9):1535–43.CrossRefPubMed
27.
go back to reference Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101–7.CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101–7.CrossRefPubMed
Metadata
Title
Ocular disease in patients with ANCA-positive vasculitis
Authors
Angela S. Watkins
John H. Kempen
Dongseok Choi
Teresa L. Liesegang
S. S. Pujari
Craig Newcomb
Robert B. Nussenblatt
James T. Rosenbaum
Jennifer E. Thorne
C. Stephen Foster
Douglas A. Jabs
Grace A. Levy-Clarke
Eric B. Suhler
Justine R. Smith
Publication date
01-03-2010
Publisher
Humana Press Inc
DOI
https://doi.org/10.1007/s12177-009-9044-4

Other articles of this Issue 1/2010

Journal of Ocular Biology, Diseases, and Informatics 1/2010 Go to the issue